eli lilly glp-1 agonist news FDA just approved orforglipron (Foundayo), Lilly's oral receptor for obesity Lilly and Resilience invest $750M
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6

















)





